MOONLAKE IMMUNOTHERAPEUTICS (MLTX) Net income 2021–2025
MOONLAKE IMMUNOTHERAPEUTICS (MLTX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$227.3MFY2025 · since FY2021: -$4.5M → -$227.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$227.3M | -91.1% |
| FY2024 | -$118.9M | -230.3% |
| FY2023 | -$36.0M | +27.9% |
| FY2022 | -$50.0M | -1000.1% |
| FY2021 | -$4.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice